AbbVie Inc. - Common Stock (ABBV)

Historical Holders from Q1 2014 to Q3 2025

Symbol: ABBV on NYSE
Type / Class: Equity / Common Stock
Shares outstanding: 1,767,364,935
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 1,267,874,137
Holdings value: $293,300,172,844
% of all portfolios: 0.265%
Number of holders: 3,840
Number of buys: 1,878
Number of sells: -1,556
Average buys %: +0.02%
Average sells %: -0.02%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of AbbVie Inc. - Common Stock (ABBV)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
VANGUARD GROUP INC	10.03%		$32,904,227,684		177,266,703		The Vanguard Group	30 Jun 2025

Institutional Holders of AbbVie Inc. - Common Stock (ABBV)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	1,267,874,137	$293,300,172,844	-$3,157,012,265	$3,260,213,682	$3,868,350,915	$231.54	3,840
2025 Q2	1,287,075,257	$238,891,385,274	+$4,866,082,603	$1,797,602,761	$2,919,906,326	$185.62	3,741
2025 Q1	1,261,493,107	$264,023,235,689	-$2,130,141,483	$3,003,489,400	$3,497,390,524	$209.52	3,780
2024 Q4	1,275,092,654	$226,558,537,921	+$1,209,556,751	$2,445,703,053	$2,754,345,786	$177.7	3,709
2024 Q3	1,263,246,128	$249,268,364,641	+$88,413,171	$2,367,926,934	$3,307,625,935	$197.48	3,466
2024 Q2	1,262,725,926	$216,474,972,193	+$1,915,850,329	$1,649,670,677	$2,210,321,599	$171.52	3,339
2024 Q1	1,253,088,393	$227,875,219,935	+$2,788,759,396	$2,074,828,173	$2,804,834,196	$182.1	3,353
2023 Q4	1,239,748,668	$192,192,568,041	+$1,517,401,072	$1,986,118,728	$3,618,729,839	$154.97	3,297
2023 Q3	1,228,903,942	$183,197,476,249	+$1,009,113,820	$1,804,109,231	$2,973,131,015	$149.06	3,092
2023 Q2	1,221,315,614	$164,787,374,519	-$1,664,070,544	$1,512,797,188	$2,170,160,287	$134.73	3,053
2023 Q1	1,233,425,991	$196,519,460,228	+$259,081,467	$1,596,261,512	$2,692,241,166	$159.37	3,117
2022 Q4	1,235,502,434	$199,621,628,438	+$2,752,393,686	$2,290,388,788	$2,393,807,814	$161.61	3,144
2022 Q3	1,221,220,466	$164,097,646,774	+$170,284,213	$1,458,854,539	$1,866,537,438	$134.21	2,949
2022 Q2	1,217,745,031	$186,477,353,594	+$3,489,007,770	$1,923,885,102	$2,311,637,170	$153.16	2,980
2022 Q1	1,203,308,144	$195,040,563,504	+$2,450,810,000	$2,568,853,113	$2,946,832,803	$162.11	3,033
2021 Q4	1,188,323,728	$160,862,723,207	+$1,040,998,406	$2,767,338,440	$4,183,383,220	$135.4	2,954
2021 Q3	1,177,170,536	$127,005,644,713	-$384,320,770	$1,970,000,218	$1,974,257,898	$107.87	2,641
2021 Q2	1,182,050,895	$133,115,260,852	-$647,210,591	$2,040,908,944	$2,029,675,264	$112.64	2,657
2021 Q1	1,186,224,948	$128,344,178,557	-$1,087,268,478	$1,650,387,862	$1,405,396,942	$108.22	2,595
2020 Q4	1,197,885,694	$128,301,295,744	-$1,070,454,735	$2,246,460,736	$1,877,551,059	$107.15	2,580
2020 Q3	1,210,244,308	$105,941,681,033	-$1,507,877,911	$1,681,382,151	$1,210,542,866	$87.59	2,356
2020 Q2	1,226,149,387	$120,286,919,217	+$14,394,795,664	$1,804,574,310	$1,645,069,532	$98.18	2,397
2020 Q1	1,079,313,793	$82,241,542,825	+$791,234,318	$1,460,218,000	$1,243,937,000	$76.19	2,213
2019 Q4	1,067,427,836	$94,486,529,954	+$1,223,798,676	$1,921,930,000	$1,683,262,000	$88.54	2,231
2019 Q3	1,056,424,195	$79,981,092,369	+$2,749,727,052	$1,471,204,000	$1,422,117,000	$75.72	1,995
2019 Q2	1,020,107,599	$74,140,080,434	+$134,418,416	$1,190,600,000	$1,187,456,000	$72.72	2,013
2019 Q1	1,025,594,398	$82,642,729,287	-$1,357,273,013	$1,061,100,000	$890,098,000	$80.59	2,023
2018 Q4	1,043,063,858	$96,057,755,521	-$2,268,195,432	$994,472,000	$997,789,000	$92.19	2,054
2018 Q3	1,064,303,780	$100,606,565,412	-$228,478,920	$1,075,537,000	$782,868,000	$94.58	1,952
2018 Q2	1,066,935,394	$98,824,334,101	-$4,621,865,658	$1,060,399,000	$787,678,000	$92.65	1,988
2018 Q1	1,115,897,507	$105,577,975,508	-$635,075,420	$1,008,734,185	$866,517,640	$94.65	2,010
2017 Q4	1,124,483,239	$108,727,093,427	+$374,684,079	$1,158,926,724	$943,730,639	$96.71	1,990
2017 Q3	1,118,458,594	$99,379,513,075	+$1,309,956,795	$735,637,000	$1,048,884,000	$88.86	1,792
2017 Q2	1,104,509,124	$80,068,623,904	+$1,082,850,124	$680,266,324	$935,018,000	$72.51	1,761
2017 Q1	1,097,772,439	$71,530,343,434	+$6,012,078,996	$849,394,000	$1,065,459,000	$65.16	1,725
2016 Q4	1,094,423,119	$68,517,301,870	-$1,501,669,878	$724,479,000	$856,455,000	$62.62	1,686
2016 Q3	1,115,082,886	$70,272,962,866	-$935,916,366	$535,426,000	$526,748,000	$63.07	1,642
2016 Q2	1,128,170,500	$69,822,885,108	+$1,331,070,628	$793,895,000	$751,364,000	$61.91	1,624
2016 Q1	1,107,228,663	$63,240,024,329	-$234,331,465	$432,577,000	$384,045,000	$57.12	1,624
2015 Q4	1,114,783,288	$66,029,826,303	-$1,761,226,133	$753,133,000	$594,693,000	$59.24	1,627
2015 Q3	1,135,736,480	$61,795,060,747	-$3,097,342,097	$759,983,000	$1,045,390,000	$54.41	1,586
2015 Q2	1,197,000,259	$80,428,666,659	+$5,904,487,622	$1,009,534,000	$1,276,743,000	$67.19	1,642
2015 Q1	1,111,667,985	$65,099,745,699	-$591,285,996	$693,078,000	$852,818,000	$58.54	1,590
2014 Q4	1,121,324,839	$73,375,310,991	-$8,392,175,216	$595,497,000	$1,020,129,000	$65.44	1,596
2014 Q3	1,252,517,869	$72,342,438,122	+$8,158,820,153	$391,264,000	$679,916,000	$57.76	1,493
2014 Q2	1,110,338,015	$62,659,470,218	+$2,575,063,702	$153,241,244	$212,153,875	$56.44	1,448
2014 Q1	1,066,968,421	$54,829,249,328	+$103,303,847	$135,024,000	$252,807,000	$51.4	1,413